Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Europe Ventures
New York, New York, United States
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
New Europe Ventures (NEV) is a venture capital firm that invests in early-stage technology and life science companies, primarily those with roots in Central and Eastern Europe and a presence in the United States. The firm focuses on sectors such as biotechnology, medical devices, and information technology, providing capital and strategic guidance to help startups scale globally. NEV leverages its dual presence in New York and Warsaw to bridge the gap between European innovation and American markets. Its portfolio includes several prominent biotech companies that have successfully transitioned from regional startups to international players.
- Industry
- Investors
Beyond the preview
Go deeper on New Europe Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New Europe Ventures.